Top Story

Espresso, cappuccino lower prostate cancer risk

May 25, 2017

Drinking 3 or more cups of Italian-style coffee, such as caffé espresso and moka, as well as their combinations with milk, including caffé latte, cappuccino and macchiato, each day can reduce the risk of prostate cancer, according to epidemiological findings published in International Journal of Cancer.

“In recent years, we have seen a number of international studies on this issue, but scientific evidence has been considered insufficient to draw conclusions,” George Pounis, PhD, from the department of epidemiology and prevention at IRCCS Neuromed in Italy, said in a press release. “Moreover, in some cases results were contradictory.”

In the Journals Plus

Screen-detected breast cancers persist without treatment

May 25, 2017
Screen-detected breast cancers that went untreated remained visible and suspicious for malignancy at next

Poor diet in adolescence, early adulthood increases risk for premenopausal breast cancer

May 25, 2017
Women who consumed an inflammation-promoting diet during adolescence and young adulthood demonstrated increased risk for premenopausal breast cancer, according to study…
FDA News

FDA advisory committee expresses support for L-glutamine for sickle cell disease

May 24, 2017
An FDA panel today expressed its support for the approval of L-glutamine powder in the treatment of sickle cell disease. The Oncologic Drugs Advisory Committee (ODAC)…

Congressional Budget Office estimates $119 billion in savings over 10 years for House-passed AHCA

May 24, 2017
The Congressional Budget Office — a non-partisan scoring agency — and the staff of the Joint Committee on Taxation released its cost estimate for the…
More News Headlines »

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Meeting News

VIDEO: Managing immune-related adverse events requires multidisciplinary approach

April 13, 2017
More »
ASCO Annual Meeting

ASCO Annual Meeting


The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today